News and events
The ProteRNA project, Success Story of the month in the SATT network
This project aims to offer RNA vaccines that can be administered orally. It is based on a method of manufacturing tablets containing nucleic acid vectors, which can be stored at room temperature.
A collaboration between UTCBS and I2M (Bordeaux)
SFnano 2023 Pauline wins best poster award!
SFnano 2023
Ouverture d’un poste AI Mobilité Interne CNRS (FSEP)
Nous avons obtenu un poste en mobilité CNRS (FSEP) pour notre plateforme d’imagerie LIOPA ( affilié PIV imagerie du vivant université paris Cité ) Profil : Assistant Ingénieur expérimentation animal. Contacts : Nathalie Mignet Johanne Seguin Fiche de poste : Fiche de...
Shanghai ranks Université Paris Cité 3rd
Shanghai ranks Université Paris Cité 3rd
Team Vecteur and Materia Nova make the front page of ChemSusChem
Team Vecteur and Materia Nova make the front page of ChemSusChem
The Nobel Prize
Nobel Prize of Physiology or Medicine 2023 toKatalin Karikó and Drew Weissman for their discoveries on nucleoside base modifications that enabled the development of effective mRNA vaccines against Covid-19.
Validation of a formulation from UTCBS to reduce recurrence rates after local treatment of colorectal cancer,
A new formulation for the treatment and prevention of colon cancer metastases.
Start-up Imisca and Erganeo have signed an exclusive license for a new gel-forming solution to reduce recurrence rates after local treatment of colorectal cancer, improve patient survival and optimize treatment.
UTCBS takes part in the 6th NanoMed Workshop in Patras (Greece)
From July 10 to 12, 2023, the 6th EMJMD NanoMed Workshop will be held in Patras (Greece) on the theme of positioning Nanomedicine in the post-vaccine RNA-messenger era.
The French Society of Nanomedicine organizes a seminar on the role of Nanomedicine in gene therapy and imaging
1st Seminar on Nanomedicine Applications in Nucleic Acid Delivery and Imaging "The SFNano (French Society of Nanomedicine) is organizing a seminar on the role of Nanomedicine in gene therapy and imaging. It will take place at the Faculty of Pharmacy of the...
seminar in nanomedicine “young researcher” to be held at the Faculty of Pharmacy on June 9
Formulations based on phase transition polymers or "Sol-Gel" are an important part of our research. These formulations have the particularity to be totally liquid during manufacturing and to gel during their application, thus conferring multiple advantages. This axis...
pFAR mini-plasmid developed at UTCBS
Témoignages émouvants des premiers patients traités. Les mini-plasmides pFAR (Free of Antibiotic Resistance marker), développés pour des approches de Thérapie Génique au sein de l’UTCBS par Corinne Marie (ChimieParistech, PSL) et Daniel Scherman (CNRS), sont entrés...
